What clinicians should know about differential placebo effects

被引:4
|
作者
Osani, Mikala C. [1 ]
Bannuru, Raveendhara R. [1 ]
机构
[1] Tufts Med Ctr, Ctr Treatment Comparison & Integrat Anal, 800 Washington St, Boston, MA 02111 USA
关键词
efficacy paradox; network meta-analysis; placebo; RANDOMIZED CONTROLLED-TRIALS; NETWORK METAANALYSIS; OSTEOARTHRITIS; ARTHRITIS; EFFICACY; PAIN;
D O I
10.2217/cer-2015-0005
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Research is inconclusive as to whether placebo interventions can result in clinical improvement. A number of methodological concepts must be taken into consideration when estimating differential effects of placebo interventions. Using network meta-analysis, researchers can move beyond the lack of direct comparisons available between different placebo interventions by making multiple pairwise comparisons. This design allows us to account for several components of the placebo effect. The additive effects of placebos may be beneficial in clinical practice if physicians can utilize them in a non-deceptive manner to optimize patient care. Researchers and clinicians should be aware of the existence of differential placebo responses when considering selecting appropriate placebo controls in the design of future clinical trials and when formulating treatment regimens.
引用
收藏
页码:289 / 296
页数:8
相关论文
共 50 条
  • [1] What clinicians should know about the QT interval
    Al-Khatib, SM
    LaPointe, NMA
    Kramer, JM
    Califf, RM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (16): : 2120 - 2127
  • [3] What Clinicians Should Know About the 2014 Ebola Outbreak
    Tosh, Pritish K.
    Sampathkumar, Priya
    [J]. MAYO CLINIC PROCEEDINGS, 2014, 89 (12) : 1710 - 1717
  • [4] An Update About Tobacco and Cancer: What Clinicians Should Know
    Steven A. Schroeder
    [J]. Journal of Cancer Education, 2012, 27 : 5 - 10
  • [5] An Update About Tobacco and Cancer: What Clinicians Should Know
    Schroeder, Steven A.
    [J]. JOURNAL OF CANCER EDUCATION, 2012, 27 (01) : 5 - 10
  • [6] What should clinicians know about the use of glucocorticoids in systemic sclerosis?
    Iudici, Michele
    [J]. MODERN RHEUMATOLOGY, 2017, 27 (06) : 919 - 923
  • [7] What Pediatricians and Other Clinicians Should Know About Zika Virus
    Kline, Mark W.
    Schutze, Gordon E.
    [J]. JAMA PEDIATRICS, 2016, 170 (04) : 309 - 310
  • [8] What Clinicians Should Know About Spontaneous Coronary Artery Dissection
    Tweet, Marysia S.
    Gulati, Rajiv
    Hayes, Sharonne N.
    [J]. MAYO CLINIC PROCEEDINGS, 2015, 90 (08) : 1125 - 1130
  • [9] A survey of what clinicians should know
    Lancaster, M
    [J]. ADMINISTRATION AND POLICY IN MENTAL HEALTH, 1997, 25 (01): : 83 - 85
  • [10] Biosimilars: what clinicians should know
    Weise, Martina
    Bielsky, Marie-Christine
    De Smet, Karen
    Ehmann, Falk
    Ekman, Niklas
    Giezen, Thijs J.
    Gravanis, Iordanis
    Heim, Hans-Karl
    Heinonen, Esa
    Ho, Kowid
    Moreau, Alexandre
    Narayanan, Gopalan
    Kruse, Nanna A.
    Reichmann, Gabriele
    Thorpe, Robin
    van Aerts, Leon
    Vleminckx, Camille
    Wadhwa, Meenu
    Schneider, Christian K.
    [J]. BLOOD, 2012, 120 (26) : 5111 - 5117